Clareon TruPlus Intraocular Lens Outcomes in Cataract Surgery
Official title: Visual and Patient Reported Outcomes of Clareon TruPlus IOL in Cataract Surgery Patients
Run by OVO LASIK + Lens · NCT07648355 · Data updated 2026-11-12
This study tests Clareon TruPlus intraocular lenses in adults undergoing cataract surgery to see how well they perform visually and respond to patient-reported questions up to 3 months after the procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | OVO LASIK + Lens Academic / other |
| Locations | 1 site (Saint Louis Park, Minnesota) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | July 11, 2027 |
| Study ends | July 11, 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07648355 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 40 undergoing age-related cataract surgery with good preoperative visual potential (best-corrected vision ~20/25 or better in both eyes) and corneal astigmatism amenable to correction with a toric lens up to 0.75 diopters.
✕Probably not a fit
Patients with significant ocular comorbidities, irregular astigmatism, prior complex ocular surgery, or conditions expected to affect vision may not benefit from the lens performance evaluated here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-site observational study evaluating Clareon TruPlus intraocular lenses in adults with age-related cataracts. It involves two surgeons performing procedures and collects refractive outcomes, visual acuity, and responses to the IOLSAT questionnaire up to 3 months post-operatively. The study does not randomize treatments or have a control arm. Eligible participants are adults over 40 with good preoperative visual potential and refractive targets compatible with mild astigmatism, while excluding those with significant ocular comorbities or prior ocular surgery beyond minor lid procedures. Outcomes will inform real-world performance of Clareon TruPlus lenses in this patient population.
Why it matters
Potential benefit: If successful, the study could provide real-world data on Clareon TruPlus lens performance and patient satisfaction after cataract surgery.
How similar studies have gone: Previous studies on Clareon TruPlus and similar IOLs have shown favorable visual outcomes and patient satisfaction in observational settings, though results vary by population and methodology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to understand and sign informed consent. * Adult patients (\>40 years old) undergoing age-related cataract surgery with expected best-corrected visual outcomes of 20/25 or better in both eyes pre-operatively as determined by surgeon and with regular corneal astigmatism correctable to less than 0.75 diopters post-operatively with no more than a T6 toric power IOL. * Normal ocular findings aside from cataract and mild dry eye. Exclusion Criteria: * Subjects targeted for monovision. * Moderate-severe corneal pathology, irregular astigmatism, preexisting macular disease and other retinal degenerative diseases, diabetic retinopathy that is expected to cause future vision loss, glaucoma, severe dry eye disease, nystagmus, strabismus, amblyopia, zonular laxity or dehiscence, pseudoexfoliation. * Previous history of any ocular surgery including LASIK (excluding minor lid procedures). * Patients with irregular astigmatism/topography, corneal dystrophies, and pupil abnormalities. * Participation in another clinical study that could interfere with the results. * Any active ocular infection or inflammation.
Where it's running
-
Ovo Lasik + Lens
Saint Louis Park, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Martha Whiting, MD — OVO Lasik and Lens LLC
- Study coordinator: Ashley Prepeluh
- Email: ashley.prepeluh@ovoeye.com
- Phone: 952-204-5060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.